Attributable cost of methicillin resistance: an issue that is difficult to evaluate
- PMID: 16934109
- PMCID: PMC1750996
- DOI: 10.1186/cc4994
Attributable cost of methicillin resistance: an issue that is difficult to evaluate
Abstract
Estimating the consequences and the cost of methicillin resistance is a difficult challenge. Patients who develop methicillin-resistant ventilator-associated pneumonia (VAP) are very different from those who develop methicillin-sensitive VAP, and biased estimates are frequent. We reviewed some important confounding factors of which the reader should be aware.
Comment on
-
Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.Crit Care. 2006;10(3):R97. doi: 10.1186/cc4934. Epub 2006 Jun 29. Crit Care. 2006. PMID: 16808853 Free PMC article.
References
-
- Bornstain C, Azoulay E, De Lassence A, Cohen Y, Costa MA, Mourvillier B, Descorps-Declere A, Garrouste-Orgeas M, Thuong M, Schlemmer B, et al. Sedation, sucralfate, and antibiotic use are potential means for protection against early-onset ventilator-associated pneumonia. Clin Infect Dis. 2004;38:1401–1408. doi: 10.1086/386321. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
